# Savanna Biotherapeutics, Inc. — Form D

Savanna Biotherapeutics, Inc. of ALISO VIEJO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-18. The offering totals $54.3M, of which $24.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-11-18
- Form: D
- Accession: 0001873404-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $54.3M
- Amount sold: $24.3M
- Remaining: $30.0M
- Investors: 54
- Date of first sale: 2022-11-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-465212

## Issuer

- Name: Savanna Biotherapeutics, Inc.
- CIK: 0001873404
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O UNIVERSITY LAB PARTNERS, CURIE HALL, ALISO VIEJO, CA, 92656
- Phone: 716-969-2573

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Michael L Speiser | Director | Palo Alto, CA |
| Jeffrey W Bird | Director | Palo Alto, CA |
| Robert Spitale | Director | Aliso Viejo, CA |
| Robert Spitale | Executive Officer | Aliso Viejo, CA |
| Keith W Loebner | Director | Palo Alto, CA |
| Kim W Kamdar | Director | Nissequogue, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-06-30](https://search.stillhousedata.com/formd/0001873404-25-000002) | D | $60.0M | $13.0M |

## More

- [CIK 1873404 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1873404&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001873404-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.